Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS10019798HBVENSG00000198650.11protein_codingTATNoNo6898P17735
TVIS10006499HBVENSG00000198650.11protein_codingTATNoNo6898P17735
TVIS10059337HBVENSG00000198650.11protein_codingTATNoNo6898P17735
TVIS10060312HBVENSG00000198650.11protein_codingTATNoNo6898P17735
TVIS10060313HBVENSG00000198650.11protein_codingTATNoNo6898P17735
TVIS44014764HTLV-1ENSG00000198650.11protein_codingTATNoNo6898P17735
TCGA Plot Options
Drug Information
GeneTAT
DrugBank IDDB00120
Drug NamePhenylalanine
Target IDBE0000692
UniProt IDP17735
Regulation Type
PubMed IDs9356140; 2890101; 16666560; 11299302
CitationsLuong TN, Kirsch JF: A continuous coupled spectrophotometric assay for tyrosine aminotransferase activity with aromatic and other nonpolar amino acids. Anal Biochem. 1997 Nov 1;253(1):46-9.@@Rege AA: Purification and characterization of a tyrosine aminotransferase from Crithidia fasciculata. Mol Biochem Parasitol. 1987 Aug;25(1):1-9.@@De-Eknamkul W, Ellis BE: Behavior of Free Aromatic Amino Acid Pools in Rosmarinic Acid-Producing Cell Cultures of Anchusa officinalis L. Plant Physiol. 1989 Feb;89(2):429-33.@@Patrizio M, Colucci M, Levi G: Human immunodeficiency virus type 1 Tat protein decreases cyclic AMP synthesis in rat microglia cultures. J Neurochem. 2001 Apr;77(2):399-407.
GroupsApproved; Investigational; Nutraceutical
Direct ClassificationPhenylalanine and derivatives
SMILESN[C@@H](CC1=CC=CC=C1)C(O)=O
PathwaysPhenylalanine and Tyrosine Metabolism; Tyrosinemia Type 2 (or Richner-Hanhart Syndrome); Tyrosinemia Type 3 (TYRO3); Phenylketonuria
PharmGKBPA450931
ChEMBLCHEMBL301523